The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Regional distribution of serotonin transporter protein in postmortem human brain
Abstract
Introduction The primary approach in assessing the status of brain serotonin neurons in human conditions such as major depression and exposure to the illicit drug ecstasy has been the use of neuroimaging procedures involving radiotracers that bind to the serotonin transporter (SERT). However, there has been no consistency in the selection of a "SERT-free" reference region for the estimation of free and nonspecific binding, as occipital cortex, cerebellum and white matter have all been employed.Objective and methods To identify areas of human brain that might have very low SERT levels, we measured, by a semiquantitative Western blotting procedure, SERT protein immunoreactivity throughout the postmortem brain of seven normal adult subjects.Results Serotonin transporter could be quantitated in all examined brain areas. However, the SERT concentration in cerebellar cortex and white matter were only at trace values, being approximately 20% of average cerebral cortex and 5% of average striatum values.Conclusion Although none of the examined brain areas are completely free of SERT, human cerebellar cortex has low SERT binding as compared to other examined brain regions, with the exception of white matter. Since the cerebellar cortical SERT binding is not zero, this region will not be a suitable reference region for SERT radioligands with very low free and nonspecific binding. For SERT radioligands with reasonably high free and nonspecific binding, the cerebellar cortex should be a useful reference region, provided other necessary radioligand assumptions are met.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In normal post-mortem human cerebellum, there is a relatively low concentration of 5-HT transporters (SERT) compared to other brain regions except in the white matter and can be used as a reference region in binding studies looking at other brain regions with higher binding densities [184].”
From Consensus Paper: Pathological Role of the Cerebellum in Autism (2012) · cites this paper as [184]
Citations
Cites
Ichise, M., Liow, J., Lu, J., Takano, A., Modell, K. J., Toyama, H., Suhara, T., Suzuki, K., Innis, R. B., & Carson, R. E. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000085441.37552.ca · Cited by 651
Tritiated Imipramine Binding Sites Are Decreased in the Frontal Cortex of Suicides
Stanley, M., Virgilio, J., & Gershon, S. (1982) · Science · doi:10.1126/science.7079769 · Cited by 473
Innis, R. B., Seibyl, J. P., Scanley, B. E., Laruelle, M. A., Abi‐Dargham, A., Wallace, E. A., Baldwin, R. M., Zea‐Ponce, Y., Zoghbi, S. S., & Wang, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11965 · Cited by 359
Meyer, J. H., Wilson, A. A., Ginovart, N., Goulding, V. S., Hussey, D. F., Hood, K., & Houle, S. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.11.1843 · Cited by 339
Self-citationHoule, S., Ginovart, N., Hussey, D., Meyer, J. H., & Wilson, A. A. (2000) · European Journal of Nuclear Medicine · doi:10.1007/s002590000365 · Cited by 276
Self-citationQian, Y., Melikian, H. E., Rye, D., Levey, A. I., & Blakely, R. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-02-01261.1995 · Cited by 256
Wilson, A. A., Ginovart, N., Schmidt, M. E., Meyer, J. H., Threlkeld, P. G., & Houle, S. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000079i · Cited by 249
Self-citationBernheimer, H., Birkmayer, W., & Hornykiewicz, O. (1961) · Journal of Molecular Medicine · doi:10.1007/bf01487648 · Cited by 240
Isolation of a cDNA encoding the human brain serotonin transporter
Lesch, K., Wolozin, B. L., Estler, H.-C., Murphy, D. L., & Riederer, P. F. (1993) · Journal of Neural Transmission · doi:10.1007/bf01244919 · Cited by 226
Cortés, R., Soriano, E., Pazos, Á., Probst, A., & Palacios, J. M. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90282-5 · Cited by 217
Cited by
Sorted by citations
Items 101–180 of 180
Kang, H.-H., Wang, C., Chen, H., Li, I., Cheng, C., Liu, R.-S., Huang, W.-S., Shiue, C., & Ma, K. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.06.049 · Cited by 23
Chou, Y.-H., Hsieh, W.-C., Chen, L.-C., Lirng, J.-F., & Wang, S.-J. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.10.056 · Cited by 23
Yang, K., Liu, M., Liou, Y., Hu, L., Yang, B., & Chou, Y.-H. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.01.018 · Cited by 22
Kim, J., Son, Y., Kim, J.-H., Choi, E., Lee, S., Lee, J. E., Cho, Z., & Kim, Y.-B. (2014) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2014.10.022 · Cited by 22
Stehouwer, J. S., & Goodman, M. M. (2009) · PET Clinics · doi:10.1016/j.cpet.2009.05.006 · Cited by 20
Cavanagh, J., Patterson, J., Pimlott, S., Dewar, D., Eersels, J., Dempsey, M. F., & Wyper, D. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.06.029 · Cited by 21
Joling, M., Vriend, C., van der Zande, J. J., Lemstra, A. W., van den Heuvel, O. A., Booij, J., & Berendse, H. W. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.04.009 · Cited by 20
Availability of the serotonin transporter in patients with alcohol dependence
Ho, P., Shih, M.-C., Ma, K., Huang, W.-S., Ho, K. K.-J., Yen, C.-H., Lu, R., & Huang, S. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2010.503813 · Cited by 20
Stehouwer, J. S., Jarkas, N., Zeng, F., Voll, R. J., Williams, L., Camp, V. M., Malveaux, E., Votaw, J. R., Howell, L. L., Owens, M. J., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800781a · Cited by 19
Risinger, R. C., Bhagwagar, Z., Luo, F. R., Cahir, M., Miler, L., Mendonza, A. E., Meyer, J. H., Zheng, M., & Hayes, W. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3391-3 · Cited by 18
Self-citationMolecular and functional characterization of the Gulf toadfish serotonin transporter (SERT; SLC6A4)
Amador, M. H. B., & McDonald, M. D. (2018) · Journal of Experimental Biology · doi:10.1242/jeb.170928 · Cited by 17
Buchert, R., Thiele, F. O., Thomasius, R., Wilke, F., Petersen, K. U., Brenner, W., Mester, J., Spies, L., & Clausen, M. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106071975 · Cited by 18
Yang, H., You, L., Wang, Z., Lu, Y., Wang, X., Wu, W., Zhi, H., Rong, G., Sheng, Y., Liu, X., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.103019 · Cited by 18
Arakawa, R., Tateno, A., Kim, W., Sakayori, T., Ogawa, K., & Okubo, Y. (2016) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2016.03.006 · Cited by 16
Seo, M., Oh, M., Cho, M., Chung, S. J., Lee, C. S., & Kim, J. S. (2014) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-014-0286-0 · Cited by 16
Cerebellar heterogeneity and its impact on PET data quantification of 5-HT receptor radioligands
Ganz, M., Feng, L., Hansen, H. D., Beliveau, V., Svarer, C., Knudsen, G. M., & Greve, D. N. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16686092 · Cited by 16
Brain kinetics of the new selective serotonin transporter tracer [123I]ADAM in healthy young adults
Booij, J., & de Win, M. M. L. (2006) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2005.10.005 · Cited by 16
Imaging of serotonin transporters with [123I]FP-CIT SPECT in the human hypothalamus
Borgers, A. J., Alkemade, A., van de Giessen, E., Drent, M. L., Booij, J., Bisschop, P. H. L. T., & Fliers, E. (2013) · EJNMMI Research · doi:10.1186/2191-219x-3-34 · Cited by 16
11C and 18F PET radioligands for the serotonin transporter (SERT)
Stehouwer, J. S., & Goodman, M. M. (2013) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3011 · Cited by 15
Kalbitzer, J., Kalbitzer, U., Knudsen, G. M., Cumming, P. D., & Heinz, A. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3308-1 · Cited by 15
Janet, R., Costes, N., Mérida, I., Derrington, E. A., & Dreher, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-28667-0 · Cited by 15
Occupancy of serotonin transporter by tramadol: a positron emission tomography study with [11C]DASB
Ogawa, K., Tateno, A., Arakawa, R., Sakayori, T., Ikeda, Y., Suzuki, H., & Okubo, Y. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001764 · Cited by 14
Gryglewski, G., Klöbl, M., Berroterán-Infante, N., Rischka, L., Balber, T., Vanicek, T., Pichler, V., Kautzky, A., Klebermass, E., Reed, M. B., et al. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.04.001 · Cited by 14
Lissemore, J. I., Mulsant, B. H., Rajji, T. K., Karp, J. F., Reynolds, C. F., Lenze, E. J., Downar, J. H., Chen, R. E., Daskalakis, Z. J., & Blumberger, D. M. (2021) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.200001 · Cited by 17
Regulation of social hierarchy learning by serotonin transporter availability
Janet, R., Ligneul, R., Vermeer, A. B. L., Philippe, R., Bellucci, G., Derrington, E. A., Park, S. Q., & Dreher, J. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01378-2 · Cited by 16
Tong, J., Hornykiewicz, O., Furukawa, Y., & Kish, S. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04636.x · Cited by 13
Self-citationBeretta, E., Cuboni, G., & Deidda, G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125508 · Cited by 12
Abnormal serotonin transporter availability in the brains of adults with conduct disorder
Chang, C., Gau, S. S., Huang, W.-S., Shiue, C., & Yeh, C. (2016) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2016.07.012 · Cited by 12
Human serotonin transporter availability predicts fear conditioning
Åhs, F., Frick, A., Furmark, T., & Fredrikson, M. (2014) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2014.12.002 · Cited by 13
van de Giessen, E., & Booij, J. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1424-2 · Cited by 12
Yu, K., Qiu, C.-L., Yang, G., Zong, C.-M., Xing, H., Shao, Y., Wei, Q., & Qin, C. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.10.008 · Cited by 12
Prabhakaran, J., Majo, V. J., Milak, M. S., Pratap, M., Savenkova, L., Mann, J. J., Parsey, R. V., & Kumar, J. S. D. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.04.099 · Cited by 12
Serotonergic dysfunction in patients with impulse control disorders in Parkinson’s disease
Prange, S., Météreau, É., Klinger, H., Huddlestone, M., Oliveira, M. D., Duperrier, S., Courault, P., Redouté, J., Tremblay, L., Sgambato, V., et al. (2025) · Brain · doi:10.1093/brain/awaf087 · Cited by 13
Matsuoka, K., Yasuno, F., Shinkai, T., Miyasaka, T., Takahashi, M., Kiuchi, K., Kosaka, J., Inoue, M., Kichikawa, K., Hasegawa, M., et al. (2016) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2016.10.007 · Cited by 11
Sex differences in dementia with Lewy bodies: an imaging study of neurotransmission pathways
Boccalini, C., Nicastro, N., Peretti, D. E., Caminiti, S. P., Perani, D., & Garibotto, V. (2023) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-023-06132-4 · Cited by 11
Murrell, M. D., Cruz, D. A., Javors, M. A., & Thompson, P. M. (2014) · Journal of Forensic Sciences · doi:10.1111/1556-4029.12393 · Cited by 11
McLane, M. W., Hatzidimitriou, G., Yuan, J., McCann, U. D., & Ricaurte, G. A. (2007) · Synapse · doi:10.1002/syn.20438 · Cited by 11
Autoreceptor control of serotonin dynamics
Best, J. A., Duncan, W., Sadre‐Marandi, F., Hashemi, P., Nijhout, H. F., & Reed, M. C. (2020) · BMC Neuroscience · doi:10.1186/s12868-020-00587-z · Cited by 10
McLane, M. W., McCann, U. D., & Ricaurte, G. A. (2011) · Synapse · doi:10.1002/syn.20958 · Cited by 10
The Pathology of Methamphetamine Use in the Human Brain
Kish, S. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418679-8.00008-3 · Cited by 10
Self-citationChiu, Y.-C., Yang, B., Yang, K., Liu, M., Hu, L., Liou, Y., Chan, L.-Y., & Chou, Y.-H. (2021) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2021.111296 · Cited by 8
Schrantee, A., Solleveld, M. M., Schwantje, H., Bruin, W. B., Mutsaerts, H. J. M. M., Adriaanse, S. M., Lucassen, P. J., Booij, J., & Reneman, L. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119836229 · Cited by 9
Serotonin transporter protein in autopsied brain of chronic users of cocaine
Tong, J., Meyer, J. H., Boileau, I., Ang, L.-C., Fletcher, P. J., Furukawa, Y., & Kish, S. J. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05562-4 · Cited by 9
Self-citationExpression of the Serotonin Transporter (SERT) in the Choroid Plexuses from Buffalo Brain
Pavone, L. M., Tafuri, S., Mastellone, V., Morte, R. D., Lombardi, P., Avallone, L., Maharajan, V., Staiano, N., & Scala, G. (2007) · The Anatomical Record · doi:10.1002/ar.20610 · Cited by 8
Lissemore, J. I., Mulsant, B. H., Bonner, A. J., Butters, M. A., Chen, R. E., Downar, J. H., Karp, J. F., Lenze, E. J., Rajji, T. K., Reynolds, C. F., et al. (2021) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2021.07.005 · Cited by 8
Increased whole cerebellar serotonin in aged C57BL/6 mice
DeKorver, N. W., Lichty, D., van der Hart, M., Rassoulpour, A., & Bonasera, S. J. (2017) · Matters · doi:10.19185/matters.201702000011 · Cited by 6
Monoamine Oxidase A and Serotonin Transporter Imaging with Positron Emission Tomography
Meyer, J. H. (2014) · Springer eBooks · doi:10.1007/978-3-642-42014-6_25 · Cited by 6
Self-citationTaylor, O., Laeken, N. V., Vos, F. D., Polis, I., Bosmans, T., Goethals, I., Achten, R., Dobbeleir, A. A., Vandermeulen, E., Baeken, C., et al. (2015) · BMC Veterinary Research · doi:10.1186/s12917-015-0622-3 · Cited by 5
Interaction effect between 5-HTTLPR and HTR1A rs6295 polymorphisms on the frontoparietal network
Long, H., Liu, B., Wang, C., Zhang, X., Li, J., Yu, C., & Jiang, T. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.08.003 · Cited by 5
Molloy, E. N., Zsido, R. G., Piecha, F. A., Beinhölzl, N., Scharrer, U., Zheleva, G., Regenthal, R., Sehm, B., Nikulin, V. V., Möller, H. E., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-94009-7 · Cited by 6
Yeh, S. H., Kuo, Y.-Y., Huang, W.-S., Chiu, C., Yu, T.-H., Flores, L. G., Tsai, C.-J., Cheng, C.-Y., & Ma, K. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.837194 · Cited by 4
Anatomy of the Serotonin Transporter
Beecher, K., Belmer, A., & Bartlett, S. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-800050-2.00006-1 · Cited by 4
FURUKAWA, Y. (2025) · Juntendō Igaku/Juntendo igaku · doi:10.14789/ejmj.jmj24-0023-r · Cited by 3
Self-citationMapping cross-modal functional connectivity of major neurotransmitter systems in the human brain
Saiz-Masvidal, C., la Peña‐Arteaga, V. D., Bertolín, S., Diez, I. P., Juaneda‐Seguí, A., Martínez‐Zalacaín, I., Chavarría-Elizondo, P., Subirà, M., Menchón, J. M., Sepulcre, J., et al. (2025) · Brain Structure and Function · doi:10.1007/s00429-025-02996-4 · Cited by 4
Translational PET Imaging of Spinal Cord Injury with the Serotonin Transporter Tracer [11C]AFM
Fang, H., Rossano, S. M., Wang, X., Nabulsi, N., Kelley, B. J., Fowles, K., Ropchan, J. R., Strittmatter, S. M., Carson, R. E., & Huang, Y. H. (2022) · Molecular Imaging and Biology · doi:10.1007/s11307-021-01698-7 · Cited by 3
2′-NH2-MPTP: A Serotonin and Norepinephrine Neurotoxin
Ochroch, J. B., Bressler, A. J., Yang, H., Murphy, D. L., Altieri, S. C., & Andrews, A. M. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_77 · Cited by 3
A Novel Automatic Approach for Calculation of the Specific Binding Ratio in [I-123]FP-CIT SPECT
Rahman, M. G. M., Islam, M. M., Tsujikawa, T., & Okazawa, H. (2020) · Diagnostics · doi:10.3390/diagnostics10050289 · Cited by 3
Misunderstandings About How to Choose a Reference Region
Meyer, J. H., Wilson, A. A., Ginovart, N., & Houle, S. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.007 · Cited by 3
Self-citationDopa-Responsive Dystonia and Related Disorders
Furukawa, Y., Guttman, M., Tomizawa, Y., & Kish, S. J. (2021) · Current clinical neurology · doi:10.1007/978-3-030-75898-1_24 · Cited by 2
Self-citationMonoamine Oxidase A and Serotonin Transporter Imaging with Positron Emission Tomography
Meyer, J. H. (2020) · Springer eBooks · doi:10.1007/978-3-030-53176-8_26 · Cited by 2
Self-citationKim, J.-H., Kim, H.-K., Lee, S., Son, Y., & Kim, J.-H. (2023) · Pharmaceuticals · doi:10.3390/ph16050759 · Cited by 2
Simplified methods for SERT occupancy estimation measured with [11C]DASB PET bolus plus infusion
de León, M. P., Murgaš, M., Silberbauer, L., Hacker, M., Gryglewski, G., Hahn, A., & Lanzenberger, R. R. (2025) · NeuroImage · doi:10.1016/j.neuroimage.2025.121208 · Cited by 1
In vivo evaluation of [123I]mZIENT as a SPECT radioligand for the serotonin transporter
Batis, J. C., Barret, O., Alagille, D., Koren, A. O., Stehouwer, J. S., Cosgrove, K., Goodman, M. M., Seibyl, J. P., & Tamagnan, G. D. (2012) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2012.07.006 · Cited by 1
Biezonski, D. K. (2019) · ScholarWorks@UMassAmherst (University of Massachusetts Amherst) · doi:10.7275/1k5h-nm52
Dietary modulation of uptake transporters
Naccarati, C. (2014) · UPT. Syiah Kuala University Library (Syiah Kuala University)
Ofuchi, A. S. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2010.tde-14012011-161822
Naganawa, M., Nabulsi, N., Planeta, B. M., Gallezot, J., Lin, S.-F., Najafzadeh, S., Williams, W. A., Ropchan, J. R., Labaree, D. C., Neumeister, A., et al. (2013)
2β-Carbo[11C]methoxy-3β-(3´-((Z)-2-iodoethenyl)phenyl)nortropane
Stehouwer, J. S., & Chopra, A. (2011) · Europe PMC (PubMed Central)
2β-Carbomethoxy-3β-(4´-((Z)-2-[123I]iodoethenyl)phenyl)nortropane
Stehouwer, J. S., & Chopra, A. (2011) · Europe PMC (PubMed Central)
PET studies on the mechanisms of action of antidepressant and antipsychotic drugs
Yang, K. (2017) · Figshare
Santis, M. D. (2018) · Research Online (University of Wollongong)
Molecular imaging findings in bipolar disorder
Meyer, J. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819182-8.00016-8
Self-citationParekh, P., Begley, P., Jessop, M., Aplin, M., Missir, E., McMeekin, H., Raczek, G., Singh, N., & Dizdarevic, S. (2023) · European Journal of Hybrid Imaging · doi:10.1186/s41824-023-00181-6
Human in vivo assessment of ketamine binding of the serotonin transporter—follow up at a higher dose
Schlosser, G., Murgaš, M., Godbersen, G. M., Reichel, S., Silberbauer, L., Nics, L., Winkler, D., Stimpfl, T., Hacker, M., Kasper, S. F., et al. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1651016
Imaging and Quantification of Brain Serotonergic Activity using PET
Lundquist, P. (2006) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Loss of serotonergic function in carriers of PRKN mutations: a [11C]DASB PET study
de Natale, E. R., Wilson, H., Verghese, J. P., Mulroy, E., Antoniadis, S., Terry, A., Cavallieri, F., Avenali, M., Nigro, P., Valotassiou, V. J., et al. (2026) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07693-2
Contribution du récepteur 5-HT2B dans la transmission sérotoninergique
Quentin, E. (2017) · theses.fr (ABES) · doi:10.70675/1d7914c4zfc59z4a28z9ad7z0467a0b5b15d
Baloch, H. U., Jing, Y., Shi, J.-H., Wang, H.-F., Wu, Y., & Liu, J. H. (2026) · Animals · doi:10.3390/ani16132036
Metadata
- Authors
- Kish, S. J., Furukawa, Y., Chang, L.-J., Tong, J., Ginovart, N., Wilson, A., Houle, S., & Meyer, J. H.
- Affiliations
- Centre for Addiction and Mental Health (CA)
- Corresponding author
- Kish, Stephen J.
- ORCID
- Venue
- Nuclear Medicine and Biology
- Publisher
- Elsevier BV
- Published
- 2005-02
- Volume
- 32
- Issue
- 2
- Pages
- 123-128
- ISSN
- 0969-8051 (ISSN-L)
- OpenAlex
- W55536439
- Cited by
- 179
- References
- 33
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 1 · 2023: 5 · 2022: 3 · 2021: 8 · 2020: 8 · 2019: 4 · 2018: 7 · 2017: 10 · 2016: 6 · 2015: 6 · 2014: 13 · 2013: 12 · 2012: 11
- FWCI
- 4.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nuclear Medicine and Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Canadian Institutes of Health Research
- National Institute on Drug Abuse (DA 7182, R01DA007182)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- serotonin transporter, postmortem brain, cerebellar cortex, white matter, reference region, non-specific binding, major depressive disorder, ecstasy, serotonergic neurons
- MeSH terms
- Brain, Cadaver, Cerebellum, Humans, Membrane Glycoproteins, Middle Aged, Nerve Tissue Proteins, Neurons, Reference Values, Tissue Distribution, Blotting, Western, Membrane Transport Proteins, Serotonin Plasma Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review